InsiderClue
Stocks · Health care · Pharmaceutical Preparations

ARROWHEAD PHARMACEUTICALS, INC.

ARWR Clue Score51
United States Fiscal year ends September CIK 0000879407 Results filed 4 Aug 2026
Add to watchlist

What the insiders did Net selling

Individual transactions

5
Insider
Date
Role
Action
Shares
Price
Amount
Patrick O'Brien
21 Dec 2022
General Counsel
Exercised, kept
32,000
$6.15
$196.80K
Christopher Richard Anzalone
7 Jul 2022
Chief Executive Officer
Exercised, kept
2,501
$14.54
$36.36K
Christopher Richard Anzalone
7 Jan 2022
Chief Executive Officer
Exercised, kept
11,806
$5.19
$61.27K
Patrick O'Brien
31 Dec 2021
General Counsel
Exercised, kept
28,000
$6.15
$172.20K
Christopher Richard Anzalone
23 Dec 2021
Chief Executive Officer
Exercised, kept
11,806
$5.19
$61.27K
Showing 250 of 427 transactions. The figures above use every one of them.

What was left out

Form 4 filings counted 274
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 108
Sales straight out of an exercise 73
Sales at will 209
Transactions with no price 0
Shares from compensation/vesting 12,981,410
Sales filed before the plan box existed 176
History held since 15 Nov 2006